Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-034633
Filing Date
2024-08-30
Accepted
2024-08-30 17:10:48
Documents
3
Period of Report
2024-08-30

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 1105136
2 proxycard_001.jpg GRAPHIC 2370993
3 proxycard_002.jpg GRAPHIC 1350262
  Complete submission text file 0001493152-24-034633.txt   6223551
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41184 | Film No.: 241271047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)